Phoenixville, PA, United States of America

James C Costin

This inventor holds 1 USPTO granted patent. Top assignee: Persevere Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James C Costin. Retrieved from https://idiyas.com/inventor/james-c-costin-k9icic80

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of James C. Costin

Introduction

James C. Costin is an accomplished inventor based in Phoenixville, PA (US). He has made significant contributions to the field of antimicrobial and anticancer research. His work focuses on developing compounds that serve as effective antineoplastic and antimicrobial agents.

Latest Patents

James C. Costin holds 1 patent for his innovative work. His patent, titled "Antimicrobial and Anticancer Agents," discloses compounds of formula (I) that are useful as antineoplastic and antimicrobial agents. The patent also outlines compositions and methods for utilizing these compounds effectively.

Career Highlights

Throughout his career, James has demonstrated a commitment to advancing medical science. His research has the potential to impact the treatment of various diseases, particularly in the fields of oncology and infectious diseases. He is currently associated with Persevere Therapeutics Inc., where he continues to innovate and develop new therapeutic solutions.

Collaborations

James has collaborated with notable professionals in his field, including Thomas Mueller and Hanns Moehler. These partnerships have enhanced his research and contributed to the development of groundbreaking solutions in healthcare.

Conclusion

James C. Costin's work exemplifies the spirit of innovation in the medical field. His contributions to antimicrobial and anticancer research are paving the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…